Biosimilars & Switches · Lincoln

Biosimilars & Switches in Lincoln.

Pharmacist-led biosimilar and formulary switches — ICB-priority molecules switched, patients counselled, evidence captured. Delivered to Lincoln PCNs and GP practices from the BCS Halifax (West Yorkshire) hub — with paired cover from our Chiswick (West London) hub. BCS is the only UK provider operating this dual-hub clinical pharmacy model.

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every biosimilar and formulary switches placement in Lincoln is mobilised from one of our two clinical hubs — Halifax (West Yorkshire) as the lead and Chiswick (West London) as paired cover. The dual-hub model is unique to BCS: no other clinical pharmacy provider in the UK runs Northern and Southern hubs with shared SOPs, shared supervision and same-week cross-cover. That is what guarantees continuity of biosimilar and formulary switches for a Lincoln PCN through sickness, leave and turnover.

  • Lead delivery from the BCS Halifax (West Yorkshire) hub
  • Paired cover from BCS Chiswick (West London) — same SOPs, same supervision
  • Same-week sickness, leave and maternity cover guaranteed
  • ARRS-compliant, GPhC-registered, IP-qualified workforce
  • One SLA, one report, one escalation point

Lincoln · local context

Lincoln PCNs sit within the local East Midlands ICB (Leicester, Leicestershire and Rutland; Nottingham and Nottinghamshire; Derby and Derbyshire; Lincolnshire; or Northamptonshire).

Lincoln PCNs serve a diverse, growing population with notable diabetes prevalence — pharmacist-led SMRs and CVD optimisation drive the BCS pipeline.

What you get

What biosimilars & switches in Lincoln actually looks like.

  • ICB-priority biosimilar switches
  • Formulary alignment audits
  • Patient counselling and consent
  • Switch evidence pack for ICB
  • Monthly switch volumes reported

Lincoln · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Lincoln
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Lincoln PCNs choose BCS for biosimilar and formulary switches.

Solo recruitment for biosimilar and formulary switches in Lincoln leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Halifax (West Yorkshire)/Chiswick (West London) dual-hub.

Whether you are a single Lincoln PCN starting your first biosimilar and formulary switches programme, or a federation coordinating biosimilar and formulary switches across multiple East Midlands networks, the BCS managed model scales without changing your contract.

Frequently asked questions — Biosimilars & Switches in Lincoln.

Do you run the patient consent process?+

Yes — every switch includes pharmacist-led counselling and consent capture.

Does BCS already deliver biosimilar and formulary switches in Lincoln?+

BCS supports PCNs and GP practices across East Midlands from our Halifax (West Yorkshire) hub with paired cover from Chiswick (West London), and is actively delivering or available to mobilise biosimilar and formulary switches in Lincoln. Get in touch and we'll confirm current capacity.

What makes the dual-hub model different?+

BCS is the only UK clinical pharmacy provider running both a Northern (Halifax) and Southern (Chiswick) hub. That means same-week cross-cover, one SOP set across the country, and no service gap when staff are off — something single-hub or single-region providers cannot match.

How quickly can BCS mobilise biosimilar and formulary switches in Lincoln?+

In most cases BCS mobilises biosimilar and formulary switches for a Lincoln PCN within 4 to 6 weeks of contract sign-off, with remote prescribing back-up available from the hub sooner if needed.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call